Sean Carrick - 29 Dec 2023 Form 4 Insider Report for Nascent Biotech Inc. (NBIO)

Role
President & CEO, Director, 10%+ Owner
Signature
/s/ Sean Carrick
Issuer symbol
NBIO
Transactions as of
29 Dec 2023
Net transactions value
+$40,681
Form type
4
Filing time
27 Feb 2024, 13:46:55 UTC
Previous filing
09 Nov 2023
Next filing
10 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBIO Common Stock Other $40,681 +239,300 +1.1% $0.1700 22,709,007 29 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as part of the employment contract with the Company.